Click image to enlarge
There have been some exciting additions to Module 1 including;
Module 2 is dedicated to different drug classes classifications and their mechanisms of action including targeted therapies, monoclonal antibodies, immune checkpoint inhibitors and hormonal therapies, not just cytotoxic drugs.
Module 3 is totally new and focusses on treatment related toxicities and their management.
New learning activity!
- Interactive case study featuring patient/nurse drag and drop activity to prepare the learner to deliver patient education.
Brand new;
case study activity with role play and toxicities assessment
overview of patient-reported outcome measures (PROMs)
Toxicity management including escalation, dose modification and cumulative toxicities
Modules 6 and 7 from version 3 have been combined to make one module - module 7.
This module now includes all routes (not just orals) and has more flexibility – learners are only required to complete the eLearning and assessment on the route/s they administer. Learners can add other routes at a later stage.
Ongoing training and resources are now available for facilitators. Please visit the Facilitator Toolbox and training calendar for more information.
We would like to thank our clinical advisory committee and external review group for generously giving their time and expertise to improve this course.
Sarah Chung is a Clinical Nurse Specialist in Haematology at St George Hospital, and has over a decade of experience caring for people with cancer. She joined the eviQ Education team in 2016 to review content and lead the update of the Anti-cancer Drug Administration course and is managing the current version four release.
CONTACT SARAH